Kuno Sommer

Kuno Sommer currently works at Bachem Holding AG, as Chairman from 2012, Sunstar-Holding AG, as Chairman from 2016, Kenta Biotech AG, as Chairman from 2006, Bachem Americas, Inc., as Chairman, PDS Pathology Data Systems Co. Ag, as Chairman from 2012, Targimmune Therapeutics AG, as Chairman from 2017, Data Systems AG, as Chairman, Spexis Ltd., as Director from 2021, Ferienclub Privilège AG, as Director, and Infors AG, as Director.
Dr. Sommer also formerly worked at Givaudan SA, as Chief Executive Officer in 1999, Berna Biotech AG, as Chief Executive Officer from 2000 to 2006, Harlan Laboratories Ltd., as Chief Executive Officer, Pevion Biotech AG, as Chairman, Roche Holding AG, as Member-Executive Committee, F.
Hoffmann-La Roche Ltd., as Principal from 1986 to 1999, Crucell NV, as Chief Business Officer, and Harlan Laboratories Ltd., as Head-Contract Research.
Dr. Sommer received his Masters Business Admin degree and doctorate degree from the University of Basel.